Interim Regional Finance Head — Diagnostics Separation

The mandate

A diagnostics technology division is separating from a wider healthcare group and needs regional finance leadership before transitional arrangements end. Shared customer balances, support charges and reporting responsibilities are still being disentangled. The interim regional head will hold executive finance accountability for the separated business, ensuring that operational continuity does not depend on undocumented support from the former group.

Start is expected on 26 October 2026 for twelve months. A permanent regional finance appointment is being recruited in parallel; a written extension may be considered only within a 24-month overall engagement cap. Handover requires independently reproducible regional reporting, agreed treatment of transition balances and demonstrated ownership of recurring settlement controls. The successor must be able to explain residual separation issues without relying on private conversations with former-group personnel.

Delegated authority includes assigning finance process owners, approving supported separation journals and resolving routine transition-charge differences within ₹30 lakh. Material changes to separation consideration, settlement of disputed indemnities and new permanent organisational structures require steering committee or board approval. The interim will not make clinical, regulatory or product-safety decisions, even when those matters affect financial timing or the cost of continuing customer service.

Thirty-one staff form the finance perimeter, supported by legal, tax and technical-accounting advisers retained for the separation. Systems ownership stays with technology leadership, while finance defines the evidence needed from each interface. Acquiring additional businesses, replacing the product portfolio and undertaking a full commercial-channel redesign are excluded. The exit test is a controlled standalone operation, not a claim that every inherited commercial or technical problem has been solved.

What you will own

• Define the standalone regional finance perimeter by reconciling legal entities, customer balances and transitional service obligations, creating a control map that identifies every continuing dependency on the former group.
• Decide supported accounting and settlement treatments for transition charges within delegation, obtaining specialist opinions on disputed terms and separating financial correction from matters requiring a contractual claim process.
• Establish independent monthly reporting with documented input owners, testing whether regional finance can reproduce results when former-group staff and informal spreadsheet support are deliberately removed from the cycle.
• Lead working-capital reviews across separated entities, identifying balances whose collection or settlement depends on unresolved ownership and assigning an explicit decision route rather than allowing them to age unnoticed.
• Present separation finance risks to the steering committee with evidence, alternatives and financial consequences, reserving material indemnity and consideration decisions for the authorised body instead of disguising them as routine accounting.
• Induct the permanent appointee through a complete close and transition-settlement review, transferring decision logs, reconciliations and residual issues with named owners and a verified calendar for the following quarter.

Candidate qualifications

• Show senior regional or finance-director accountability within a 22–28-year career in healthcare, medical technology, FMCG or another regulated product environment. Establish personal ownership of multi-entity controls, standalone reporting or payment boundaries, an operational finance transition or a material entity change. Your evidence must identify financial decisions you held and demonstrate how those methods apply to separation without relying on identical transaction history.
• Demonstrate technical depth in transition balances, revenue cut-offs, intercompany settlement and financial controls. Explain how you distinguished a reporting problem from a disputed contractual obligation and how you preserved evidence for specialist review. Accounting training or equivalent senior competence should support reliable judgement; the role does not assume that finance can substitute for legal interpretation or clinical expertise.
• Have led managers through a changing organisational boundary without creating ungoverned parallel processes. Evidence should include access and input ownership, repeatable close controls and the treatment of unresolved items that could not responsibly be cleared before handover. The discussion will examine what remained open, not only the milestones announced as complete.
• Be able to begin on the specified date and sustain five-day weekly regional leadership, with planned travel where separation controls need direct examination. Bring a credible handover method that allows a successor to operate independently. The assignment demands calm authority when commercial continuity pressures conflict with documentary completeness or when several senior stakeholders prefer different interpretations of a transition obligation.

Application

Applications for this mandate are received in one way only: through the India Board Terminal's application process. It is automated end to end. Your Executive Passport travels to the mandate holder in its confidential form, your answers to the three questions below are read before anything else in your file, and every stage that follows is recorded on your applications page.

There is no address to write to and no intermediary to call. The mandate holder reads what the Terminal delivers and nothing else, which is what keeps the process the same for every applicant and keeps your name out of it until you release it. Applications close on 12 October 2026. Mandate reference CVU-INT-2026-IND-101.